Drug-Drug Interaction between Psychiatric Medications and Experimental Treatments for Coronavirus Disease-19: A Mini-Review (original) (raw)
Research Paper: Drug Interactions of Psychiatric and COVID-19 Medications
Alia Shakiba, Basic and Clinical Neuroscience Journal
2020
View PDFchevron_right
Drug Interactions of Psychiatric and COVID-19 Medications
Alia Shakiba
Basic and Clinical Neuroscience Journal, 2020
View PDFchevron_right
Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications
Parisa Ghasemiyeh
Iranian Journal of Pharmaceutical Research : IJPR, 2021
View PDFchevron_right
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents
Chris Kalafatis
Therapeutic Advances in Psychopharmacology
View PDFchevron_right
Adverse drug reactions associated with concurrent acute psychiatric treatment and Covid-19 drug therapy
Alper BÜLBÜL
International Journal of Psychiatry in Clinical Practice, 2020
View PDFchevron_right
Potential Psychotropic and COVID-19 Drug Interactions: A Comparison of Integrated Evidence From Six Database Programs
Sathvik Sridhar
Cureus, 2021
View PDFchevron_right
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
Alessandro Cuomo
BMC Medicine, 2020
View PDFchevron_right
Psychotropics and COVID-19: An analysis of safety and prophylaxis
L. Weiner
L'Encéphale, 2021
View PDFchevron_right
Psychiatric Clinical Profiles and Pharmacological Interactions in COVID-19 Inpatients Referred to a Consultation Liaison Psychiatry Unit: a Cross-Sectional Study
Cristian Llach
Psychiatric Quarterly, 2021
View PDFchevron_right
Drug-drug Interaction between Psychotropic Medications and Medications Used in COVID-19: Comparison of Online Databases
Aathira J. Prakash
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2023
View PDFchevron_right
RELEVANT DRUG INTERACTIONS BETWEEN DRUGS THAT ACT ON THE CENTRAL NERVOUS SYSTEM AND DRUGS USED TO TREAT COVID-19 (Atena Editora)
Atena Editora
RELEVANT DRUG INTERACTIONS BETWEEN DRUGS THAT ACT ON THE CENTRAL NERVOUS SYSTEM AND DRUGS USED TO TREAT COVID-19 (Atena Editora), 2022
View PDFchevron_right
Actual and potential drug interactions of psychotropic drugs in patients of the COVID-19 medicine service of the emergency hospital-Lima, 2021
ambrocio teodoro esteves pairazaman
F1000Research
View PDFchevron_right
COVID-19 inpatients with psychiatric disorders: Real-world clinical recommendations from an expert team in consultation-liaison psychiatry
Cristian Llach
Journal of Affective Disorders, 2020
View PDFchevron_right
Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
emmanuel stip
Asian Journal of Psychiatry, 2020
View PDFchevron_right
Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
Mokhtar Gomaa
Scientific Reports
View PDFchevron_right
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants—A Scoping Review
Udo Bonnet
Journal of Clinical Psychopharmacology
View PDFchevron_right
Exploring the Efficacy of Psychotropic Drug Combinations for COVID-19 Depression
Rodrigo Cé
Revista Multidisciplinar em Saúde
View PDFchevron_right
Pharmacological treatment during CoViD-19 and mental health issues
Sana Rehman
Rivista di psichiatria, 2021
View PDFchevron_right
The interface of psychiatry and COVID-19: Challenges for management of psychiatric patients
Afzal Javed
Pakistan Journal of Medical Sciences
View PDFchevron_right
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies
Alison Boyle
Journal of Antimicrobial Chemotherapy, 2020
View PDFchevron_right
Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence
Marta Torrens
Journal of Clinical Medicine
View PDFchevron_right
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State–wide Psychiatric Hospital System
Molly Finnerty
JAMA Network Open
View PDFchevron_right
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment
Milica Borovcanin
Frontiers in Psychiatry, 2020
View PDFchevron_right
Initiation of psychotropic medication in hospitalized patients with COVID‐19: Association with clinical and biological characteristics
Massimo Clerici
Human Psychopharmacology: Clinical and Experimental, 2021
View PDFchevron_right
Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic
Robert Litman
Innovations in clinical neuroscience, 2021
View PDFchevron_right
Use of anxiolytics and hypnotic drugs during COVID-19 pandemic: The literature review
Tea Trajkovski
Medicinski Podmladak, 2022
View PDFchevron_right
Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort
Catherine Clelland
BJPsych Open, 2021
View PDFchevron_right
Adverse drug reactions in SARS-CoV-2 inpatients: a case-series with a focus on drug-drug interactions
Adriana Bayona
2020
View PDFchevron_right
Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic
Paul Naarding
The British Journal of Psychiatry
View PDFchevron_right
Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study
Nicolas Hoertel
Translational Psychiatry
View PDFchevron_right
Potential Drug-Drug and Drug-Disease interactions of selected experimental therapies used in treating COVID-19 patients
radhwan Al_Zidan
View PDFchevron_right
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions
Giada Crescioli, Niccolò Lombardi
View PDFchevron_right
Prescriptions of antipsychotics dispensed in long-term care facilities during the COVID-19 pandemic
Iara Oliveira
General Hospital Psychiatry
View PDFchevron_right
Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
Nicolas Hoertel
Journal of Clinical Medicine
View PDFchevron_right